Manieri T, Takata D, Targino R, Quintilio W, Batalha-Carvalho J, da Silva C
Pharmaceutics. 2022; 14(10).
PMID: 36297421
PMC: 9611486.
DOI: 10.3390/pharmaceutics14101985.
Xu X, Yu R, Xiao L, Wang J, Yu M, Xu J
Adv Sci (Weinh). 2021; 8(15):e2002751.
PMID: 34081408
PMC: 8336487.
DOI: 10.1002/advs.202002751.
Aliprandini E, Takata D, Lepique A, Kalil J, Boscardin S, Moro A
Toxicon X. 2020; 2:100006.
PMID: 32550563
PMC: 7285915.
DOI: 10.1016/j.toxcx.2019.100006.
Yu R, Fang T, Liu S, Song X, Yu C, Li J
Toxins (Basel). 2016; 8(7).
PMID: 27348002
PMC: 4963827.
DOI: 10.3390/toxins8070194.
Beise J, Hahnen J, Dreyer F
Naunyn Schmiedebergs Arch Pharmacol. 1994; 349(1):66-73.
PMID: 8139702
DOI: 10.1007/BF00178208.
A review of the molecular structure of tetanus toxin.
Robinson J, Hash J
Mol Cell Biochem. 1982; 48(1):33-44.
PMID: 7177108
DOI: 10.1007/BF00214820.
Bacterial toxins: cellular mechanisms of action.
Middlebrook J, Dorland R
Microbiol Rev. 1984; 48(3):199-221.
PMID: 6436655
PMC: 373009.
DOI: 10.1128/mr.48.3.199-221.1984.
Membrane receptors for bacterial toxins.
Eidels L, Proia R, Hart D
Microbiol Rev. 1983; 47(4):596-620.
PMID: 6363900
PMC: 283710.
DOI: 10.1128/mr.47.4.596-620.1983.
Rapid, simplified method for production and purification of tetanus toxin.
Ozutsumi K, Sugimoto N, Matsuda M
Appl Environ Microbiol. 1985; 49(4):939-43.
PMID: 3890743
PMC: 238473.
DOI: 10.1128/aem.49.4.939-943.1985.
Tetanus toxin: biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis.
Weller U, Mauler F, Habermann E
Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(2):99-106.
PMID: 3054567
DOI: 10.1007/BF00174855.
Antibodies against the light chain of tetanus toxin in human sera.
Lin C, Habig W, HARDEGREE M
Infect Immun. 1985; 49(1):111-5.
PMID: 2409006
PMC: 262066.
DOI: 10.1128/iai.49.1.111-115.1985.
Cloning and expression of functional fragment C of tetanus toxin.
Halpern J, Habig W, Neale E, Stibitz S
Infect Immun. 1990; 58(4):1004-9.
PMID: 2318526
PMC: 258574.
DOI: 10.1128/iai.58.4.1004-1009.1990.
Isolation and purification of two antigenically active, "complimentary" polypeptide fragments of tetanus neurotoxin.
Matsuda M, Yoneda M
Infect Immun. 1975; 12(5):1147-53.
PMID: 1104484
PMC: 415410.
DOI: 10.1128/iai.12.5.1147-1153.1975.
Tetanus toxin.
Bizzini B
Microbiol Rev. 1979; 43(2):224-40.
PMID: 390355
PMC: 281472.
DOI: 10.1128/mr.43.2.224-240.1979.
Interaction of tetanus toxin and toxoid with cultured neuroblastoma cells. Analysis by immunofluorescence.
Zimmerman J, Piffaretti J
Naunyn Schmiedebergs Arch Pharmacol. 1977; 296(3):271-7.
PMID: 320489
DOI: 10.1007/BF00498693.
Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment.
Robinson J, Chen H, Hash J, Puett D
Mol Cell Biochem. 1978; 21(1):23-31.
PMID: 104144
DOI: 10.1007/BF00230193.
